Skip to main content

Dr. Andy Tao

Dr. Andy Tao

The Tao research group focuses on the development and applications of biological mass spectrometry for functional proteomics. Examining changes in proteins of interest and their modifications within cells under different physiological conditions will offer insights into understanding cellular and molecular mechanisms that cannot currently be obtained through traditional biological studies that usually focus on the detailed analysis of individual biomolecules. Tao Cartoon Image Functional proteomics thus holds significant promise for the discovery of diagnostic or prognostic protein markers, for the detection of new therapeutic targets, and as a powerful tool to further our understanding of basic biological processes and mechanisms. The realization of these expectations relies on the development of robust and highly sensitive and specific methods to identify and quantify important proteins and their specific modifications.

Current projects in the Tao Group are:
1. Molecular signaling in cancer cells: phosphoproteomics
2. Identification of biomarkers for early detection of diseases for cancer and AD
3. Chemical proteomics to understand virus and bacteria infection


  • Ph.D., Purdue University, 2001
  • Postdoctoral, Institute for Systems Biology, 2004


  • Outstanding Commercialization Award, 2017
  • University Faculty Scholar, 2011
  • Career Award, 2007
  • ASMS Research Award, 2006
  • Damon Runyon Cancer Research Fellowship, 2002


List of publications